Why do I need RNA-seq if I already have Ribo-seq?

Ribo-seq measures ribosome-protected fragments, but footprint abundance is influenced by how much transcript is present. Matched RNA-seq supplies the abundance context needed to estimate translation efficiency and distinguish a ribosome-occupancy change from a change driven mainly by RNA abundance.

Can I integrate Ribo-seq with RNA-seq generated in a previous experiment?

Sometimes. We first review sample identity, biological condition, replicate structure, reference genome, annotation version, library design, and batch differences. Matched samples generated under coordinated conditions are preferred because they reduce confounding that cannot be fully corrected computationally.

Is translation efficiency simply Ribo-seq divided by RNA-seq?

A normalized RPF-to-RNA ratio is a useful descriptive TE measure. For condition comparisons, robust differential-translation analysis should also model the two data types and their interaction rather than relying only on ratios, especially when counts are low or experimental designs are complex.

Can the service identify uORFs, alternative ORFs, and micropeptides?

Ribo-seq can provide evidence of active translation at annotated and non-canonical ORFs when footprint quality and coverage are adequate. We can include ORF and initiation analyses in scope. Candidate micropeptides should remain translation-supported candidates until additional peptide-level or functional validation is performed.

What makes a Ribo-seq dataset suitable for codon-level interpretation?

We examine RPF length distribution, mapping to coding regions, P-site assignment, start/stop metagene behavior, three-nucleotide periodicity, and replicate concordance. A library that does not support these properties may still have limited gene-level value, but we avoid overstating codon-level conclusions.

How many biological replicates should I plan?

The supplied service framework recommends three biological replicates per group and at least two biological groups for comparative studies. The optimal design depends on biological variability, effect size, sample availability, and the complexity of planned contrasts.

Translatomics
Integrated Ribo-seq & RNA-seq

Integrated Ribo-seq & RNA-seq Service - Transcriptome-Translatome Analysis of Translation Efficiency

Our integrated Ribo-seq and RNA-seq service measures gene regulation at two connected layers: transcript abundance and ribosome engagement. By profiling matched RNA and ribosome-protected fragments from the same study design, we help researchers determine whether biological changes arise from transcription, translation efficiency, or coordinated regulation across both layers.

CD Genomics coordinates experimental design, wet-lab processing, sequencing, Ribo-seq-specific quality control, RNA-seq analysis, and integrated interpretation. The result is a matched transcriptome-translatome framework for differential translation, ORF discovery, and pathway-level analysis.

Key Highlights:

Quantify translation efficiency using matched RPF and RNA-abundance information.
Separate transcriptionally driven responses from translationally exclusive, buffered, or intensified regulation.
Investigate uORFs, alternative ORFs, sORFs, initiation features, and codon-level behavior when data quality supports them.
Receive coordinated wet-lab, sequencing, QC, and bioinformatics outputs in one research workflow.

Submit Your Request Now

Integrated Ribo-seq and RNA-seq service linking transcript abundance with ribosome footprints for translation efficiency analysis

Why Integrate Comparison Workflow Analysis Interpretation Applications Samples Demo Case FAQ

Why Matched Ribo-seq and RNA-seq Matter

RNA abundance and protein synthesis are connected, but they are not interchangeable measurements. RNA-seq tells you how much transcript is present. Ribo-seq (Ribosome Profiling) captures ribosome-protected fragments (RPFs), providing a high-resolution view of where ribosomes are engaged on RNA. A change in RPF abundance can therefore reflect a change in transcript abundance, a change in translation, or both.

Matched RNA-seq provides the transcriptional context needed to interpret that RPF signal. At the gene level, translation efficiency (TE) can be summarized by comparing normalized ribosome-footprint abundance with normalized RNA abundance. For group comparisons, differential-translation models can evaluate whether the Ribo-seq response is larger, smaller, or directionally different from the RNA-seq response.

This distinction is especially useful when RNA-seq and phenotype do not agree, when protein-level observations diverge from transcript abundance, when a perturbation is expected to alter translation rapidly, or when the study needs to separate transcriptional regulation from translational buffering or reinforcement.

It is also valuable when the biological question concerns translation of uORFs, alternative ORFs, sORFs, or transcripts previously treated as non-coding. Ribo-seq can support active-translation hypotheses, while RNA-seq establishes whether the underlying transcript is present and how its abundance changes.

What the Integrated Design Reveals

Research Question	RNA-seq Alone	Ribo-seq Alone	Integrated Ribo-seq + RNA-seq
Is transcript abundance changing?	Yes	Indirectly	Yes, directly quantified
Is ribosome occupancy changing?	No	Yes	Yes, with RNA-abundance context
Can translation efficiency be estimated?	No	Incomplete without RNA context	Yes
Can transcriptional and translational effects be separated?	No	Limited	Yes, through joint modeling
Can translated ORFs and initiation features be investigated?	No	Yes	Yes, with expression context
Can pathway responses be compared across regulatory layers?	Transcriptome only	Translatome only	Yes, side-by-side and integrated

For the RNA-abundance layer, our RNA Sequencing Services provide the matched transcriptomic dataset used for expression quantification and differential analysis. We plan the two assay arms together so sample groups, biological replicates, reference annotations, and downstream contrasts remain aligned.

Flexible project entry modes

End-to-end matched study: Ribo-seq and RNA-seq from the same experimental design through sequencing and integrated analysis.
Ribo-seq plus matched RNA already available: we review sample matching, annotation version, group structure, and data compatibility before integration.
RNA-seq project with translation follow-up: we evaluate whether Ribo-seq is the right next layer and design compatible comparisons.
Expanded translatomics study: projects needing method selection can start from our Translatomics Sequencing Services portfolio.

When the primary question is active-ribosome enrichment under limited-input conditions, Enhanced Ribosome Profiling may be considered during technical consultation. When transcript-level ribosome loading rather than codon-position information is the main objective, Polysome Profiling + RNA-seq provides a complementary strategy.

Integrated Ribo-seq and RNA-seq Workflow

We use a six-stage matched workflow so the transcriptome and translatome remain comparable from study design through interpretation.

Six-step integrated Ribo-seq and RNA-seq workflow from study design and sample QC to matched sequencing and transcriptome-translatome integration

Project design and matching plan - Define biological groups, replicate structure, sample type, reference genome, translation questions, and required contrasts before laboratory work begins.
Sample receipt and quality review - Confirm sample identity, quantity, preservation, and suitability for parallel Ribo-seq and RNA-seq processing.
Parallel library preparation - Generate ribosome-protected-fragment libraries for Ribo-seq and matched transcriptome libraries for RNA-seq using project-appropriate workflows.
Sequencing and layer-specific QC - Evaluate Ribo-seq footprint features and RNA-seq read quality before integrated modeling.
Matched bioinformatics processing - Align both datasets to a coordinated reference and annotation framework, quantify RNA and RPF signals, and perform within-layer comparisons.
Transcriptome-translatome integration - Calculate TE-related metrics, identify differential translation, classify regulatory patterns, investigate ORFs and codon-level features, and interpret enriched functions.

The matched design is deliberate. Post hoc integration of unrelated datasets can introduce differences in sample handling, annotation versions, batch structure, or biological state that complicate interpretation.

Bioinformatics and Data Analysis

Analysis Module	What We Evaluate	Why It Matters
Ribo-seq read QC	Adapter/quality filtering, RPF length distribution, contaminant filtering	Confirms that the footprint library contains interpretable ribosome-associated signal
Ribo-seq mapping	Genome/transcriptome alignment and coding-region distribution	Establishes where protected fragments originate
P-site and periodicity QC	P-site assignment, start/stop metagene profiles, 3-nt periodicity	Supports codon-level interpretation of translating ribosomes
RNA-seq QC and quantification	Read QC, alignment, gene/transcript quantification	Provides the matched RNA-abundance layer
Differential RNA expression	Condition- or group-associated transcript changes	Defines transcriptional regulation
RPF differential analysis	Condition-associated changes in ribosome footprints	Defines changes in ribosome occupancy
Translation-efficiency analysis	RPF signal interpreted relative to matched RNA abundance	Separates translation changes from abundance changes
Differential translation	Joint comparison of Ribo-seq and RNA-seq responses	Identifies condition-dependent translational regulation
Regulatory classification	Forwarded, translationally exclusive, buffered, or intensified patterns	Converts two fold-change lists into mechanistic categories
ORF and initiation analysis	Annotated ORFs, uORFs, alternative ORFs, sORFs, candidate initiation sites	Extends analysis beyond conventional gene-level expression
Codon-level analysis	Codon occupancy and pausing/stalling patterns when supported by data quality	Investigates elongation-related regulation
Functional interpretation	GO/KEGG enrichment and pathway comparison	Connects regulated genes to biological processes

The exact modules are selected during project design. We do not treat every short RPF peak as evidence of a new protein, and we do not present ribosome occupancy as a substitute for direct protein measurement. Candidate novel ORFs or micropeptides should be prioritized for orthogonal validation when protein-level confirmation is required.

From Two Datasets to Interpretable Regulatory Classes

A useful integrated result is often not a single TE value. It is the pattern formed by RNA and RPF changes across conditions. We interpret these layers together rather than ranking genes from one assay in isolation.

Transcriptionally forwarded

RNA abundance changes and the Ribo-seq signal changes in a comparable direction without a clear additional TE shift. The translation layer largely carries forward the transcriptional response.

Translationally exclusive

RNA abundance remains comparatively stable while ribosome occupancy changes. These genes are candidates for regulation at the translation layer that RNA-seq alone would miss.

Translationally buffered

RNA changes in one direction, while translation efficiency counteracts that change. This pattern can reduce the effect of transcriptional variation on protein synthesis.

Translationally intensified

RNA and translation-efficiency changes act in the same direction. The translation layer reinforces the transcriptional response and increases separation between conditions.

Four-class transcriptome-translatome interpretation of forwarded, translationally exclusive, buffered, and intensified gene regulation

These categories are hypothesis-generating rather than fixed biological labels. Their reliability depends on biological replication, sample matching, Ribo-seq quality, RNA-seq quality, and an analysis model appropriate to the experimental design.

Research Applications

Drug and perturbation mechanism research

Compare translational responses with parallel RNA-abundance changes to prioritize pathways where ribosome occupancy shifts independently of transcription.

Stress-response biology

Translation can be reprogrammed rapidly during nutrient, oxidative, thermal, or other experimental stress. Integrated profiling helps separate immediate translational control from changes that are mainly transcriptional.

Development and differentiation

Identify genes whose translational regulation changes across developmental stages or cell states even when RNA abundance changes modestly.

RNA regulation and non-canonical ORFs

Investigate uORFs, alternative initiation, sORFs, and candidate translation from transcripts previously annotated as non-coding. For lncRNA-focused projects, see our lncRNA Translation & Micropeptide Profiling workflow.

Plant and animal functional genomics

Examine how environmental conditions, genotype, developmental stage, or experimental perturbation reshape translation in research models with suitable reference resources.

Quality controls that protect interpretation

Matched samples are preferred: Ribo-seq and RNA-seq should represent the same biological state and comparison structure whenever possible.
Biological replication is part of design review: replicates support reliable differential RNA and translation analysis.
Ribo-seq must pass translation-specific QC: footprint length, mapping distribution, P-site behavior, periodicity, and replicate concordance are reviewed before codon-level interpretation.
References are harmonized: genome build, gene annotation, identifiers, and contrasts are coordinated before integration.
Low-count features are interpreted cautiously: TE ratios can become unstable when RNA or RPF counts are sparse.
Novel ORFs require appropriate evidence: Ribo-seq supports active translation, while peptide identity or biological function may require additional validation.

Sample Requirements, Experimental Design, and Deliverables

Sample Type / Parameter	Standard Requirement	Notes
Cell samples	≥ 1 × 10⁶ cells per sample	Cultured or primary cells
Tissue samples	≥ 50 mg per sample	Flash-frozen without preservatives
Supported species	Human, mouse, rat	Other species upon consultation
Study groups	Minimum two groups	For example, control vs treatment
Biological replication	Three biological replicates per group recommended	Supports differential analysis
Matched assays	Ribo-seq and RNA-seq for each sample	Required for the intended integrated comparison

Why sample coordination matters

Sample handling can strongly influence ribosome occupancy. We recommend discussing collection, freezing, and experimental timing before the study begins rather than treating these as post-sequencing corrections. Final acceptance is confirmed after project-specific review.

Typical deliverables

Raw sequencing FASTQ files for Ribo-seq and RNA-seq.
Processed alignment and quantification outputs.
Ribo-seq footprint and translation-specific QC summaries.
RNA expression matrices and differential-expression results.
RPF abundance and differential ribosome-occupancy results.
Translation-efficiency metrics and differential-translation tables.
Regulatory-class assignments for transcriptional and translational responses.
ORF/uORF/alternative ORF/sORF outputs when included in scope.
Functional enrichment tables, publication-ready figures, and project report.

Demo Results - What an Integrated Report Can Show

Representative reporting views illustrate how we connect RNA abundance with ribosome occupancy. They demonstrate reporting format and analytical logic, not promised biological outcomes for a new project.

RNA-seq versus Ribo-seq fold-change scatter plot classifying transcriptional and translational regulation Figure 1. RNA-versus-RPF regulatory map
Matched fold-change coordinates separate genes that follow transcription from genes with additional translation-level regulation.

Differential translation efficiency volcano plot highlighting significant translational regulation Figure 2. Differential translation-efficiency view
A TE-focused significance plot prioritizes genes whose translation changes are not explained by RNA abundance alone.

Ribo-seq three-nucleotide periodicity and metagene quality-control plot for codon-level analysis Figure 3. Translation-specific Ribo-seq QC
Periodicity and metagene views show whether footprint behavior supports codon-level interpretation.

Transcription vs translation

See whether the RPF response simply tracks RNA abundance or departs from it.

Candidate prioritization

Focus downstream validation on genes with translation-specific changes rather than broad expression lists.

Ribo-seq interpretability

Use footprint QC to determine whether codon-level conclusions are supported by the library.

Pathway context

Compare pathway enrichment across RNA, RPF, and differential-translation outputs.

Independent Published Example: Matched Transcriptome-Translatome Analysis

Ichinose and colleagues investigated how translational regulation contributes to cell-type-specific protein expression in the Drosophila nervous system. Their study paired transcriptome and translatome measurements to distinguish changes in RNA abundance from changes in translation efficiency.

The authors performed Ribo-seq and matched RNA-seq in whole fly heads, then extended the design to genetically defined neuronal and glial populations. In the whole-head experiment, RNA-seq was generated from the same lysate without RNase digestion, enabling direct comparison of mRNA abundance with ribosome footprints.

Published eLife Figure 1 comparing Ribo-seq and RNA-seq in Drosophila head for transcriptome-translatome analysis

Published Figure 1: Comparative transcriptome-translatome analyses in the Drosophila head. Reproduced from the eLife source article under CC BY 4.0 with attribution.

In the whole-head Ribo-seq data, 96.2% of ribosome footprints mapped to annotated coding sequences and showed clear three-nucleotide periodicity. The authors analyzed 9,611 genes with reads in both Ribo-seq and RNA-seq; transcript abundance and ribosome footprints were related but not identical (R² = 0.664), and translation efficiency varied by more than 20-fold between the 5th and 95th percentiles.

Cell-type-specific comparisons further showed lower translation efficiency in glia for groups of neuron-related proteins, including ion channels and neurotransmitter receptors. Selected transcripts also displayed a 5′-leader bias in glial ribosome footprints, motivating reporter experiments on uORF-linked translational suppression.

This independent study illustrates the decision value of matched Ribo-seq and RNA-seq: RNA abundance alone would not capture the full range of translation-level regulation. It is presented as a published literature example, not a CD Genomics customer project or a performance guarantee.

FAQs - Integrated Ribo-seq & RNA-seq

- Why do I need RNA-seq if I already have Ribo-seq?
  - Ribo-seq measures ribosome-protected fragments, but footprint abundance is influenced by how much transcript is present. Matched RNA-seq supplies the abundance context needed to estimate translation efficiency and distinguish a ribosome-occupancy change from a change driven mainly by RNA abundance.
- Can I integrate Ribo-seq with RNA-seq generated in a previous experiment?
  - Sometimes. We first review sample identity, biological condition, replicate structure, reference genome, annotation version, library design, and batch differences. Matched samples generated under coordinated conditions are preferred because they reduce confounding that cannot be fully corrected computationally.
- Is translation efficiency simply Ribo-seq divided by RNA-seq?
  - A normalized RPF-to-RNA ratio is a useful descriptive TE measure. For condition comparisons, robust differential-translation analysis should also model the two data types and their interaction rather than relying only on ratios, especially when counts are low or experimental designs are complex.
- Can the service identify uORFs, alternative ORFs, and micropeptides?
  - Ribo-seq can provide evidence of active translation at annotated and non-canonical ORFs when footprint quality and coverage are adequate. We can include ORF and initiation analyses in scope. Candidate micropeptides should remain translation-supported candidates until additional peptide-level or functional validation is performed.
- What makes a Ribo-seq dataset suitable for codon-level interpretation?
  - We examine RPF length distribution, mapping to coding regions, P-site assignment, start/stop metagene behavior, three-nucleotide periodicity, and replicate concordance. A library that does not support these properties may still have limited gene-level value, but we avoid overstating codon-level conclusions.
- How many biological replicates should I plan?
  - The supplied service framework recommends three biological replicates per group and at least two biological groups for comparative studies. The optimal design depends on biological variability, effect size, sample availability, and the complexity of planned contrasts.